68Ga-DOTATATE PET/CT in Neuroendocrine Tumor
NCT04041882
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
68Ga-DOTATATE
Sponsor
Peking Union Medical College Hospital